Fennec Pharmaceuticals, Inc.

Fennec Pharmaceuticals, Inc.

Fennec Pharmaceuticals, Inc.

Overview
Date Founded

2011

Headquarters

Research Triangle Park,68 T.W. Alexander Drive,Durham, NC 27709

Type of Company

Public

Employees (Worldwide)

4

Industries

Pharmaceuticals
Biotechnology

Company Description

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Contact Data
Trying to get in touch with decision makers at Fennec Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman of the Board & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Commercial Officer

Controller

Member, Management Team

Member, Management Team

Chief Financial Officer

Board of Directors

Partner at Sirius Healthcare Partners GmbH

Senior Vice President & General Manager-EMEA Region at PTC Therapeutics, Inc.

Chief Operating Officer at Agilis Biotherapeutics, Inc.

Chief Executive Officer & Global Head, Rare Disease-Sigma Tau Rare Disease Ltd at ESSETIFIN SpA

Paths to Fennec Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Fennec Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

SCA is a value-oriented investment adviser that focuses primarily on US corporate equity, but also invests in other securities and investments on behalf of the Funds. Their funds seek high absolute investment returns, while minimizing the risk of capital loss, by purchasing securities and other financial instruments with trading values substantially below their intrinsic value and selling short securities and other financial instruments with trading values substantially above their intrinsic value. The firm primarily constructs its portfolio from the bottom-up.

Details Hidden

SCM’s investment approach focuses on fundamental value with respect to specific securities, both in long and short strategies, that intends both to achieve absolute investment returns and preserve capital, irrespective of market conditions. The firm uses primary research and fundamental bottom-up analysis in an attempt to develop a deep, fundamental view of companies and to identify opportunities across investment instruments.

Details Hidden

SCM’s investment approach focuses on fundamental value with respect to specific securities, both in long and short strategies, that intends both to achieve absolute investment returns and preserve capital, irrespective of market conditions. The firm uses primary research and fundamental bottom-up analysis in an attempt to develop a deep, fundamental view of companies and to identify opportunities across investment instruments.

Recent Transactions
Details Hidden

Fennec Pharmaceuticals, Inc. issued USD Common Shares

Details Hidden

Fennec Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Fennec Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors
Auditor

Advised onFennec Pharmaceuticals, Inc. issued CAD Units

Underwriter

Advised onFennec Pharmaceuticals, Inc. issued CAD Units

Escrow Agent

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Legal Advisor

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Legal Advisor

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Head of Investment Banking

Advised onFennec Pharmaceuticals, Inc. issued USD Common Shares

Key Stats and Financials As of 2019
Market Capitalization
$193M
Total Enterprise Value
$110M
Earnings Per Share
$-0.62
TEVNet Income
-8.87x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Five Year Compounded Annual Growth Rate Of Revenue
0%
Revenue
$0
Net Profit
$-12.4M
EBITDA
$-12.6M
Total Debt
$0
Total Equity
$11.3M
Non-Profit Donations & Grants
Suppliers
Oregon Health & Science University Hospitals & Patient Services | Portland, OR

Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. OHSU is the kind of place where the big news doesn't always involve sports, politics, fashion or even weather. The big news is always about health — health care, health education, health-related research. And various organizations and publications that rank American institutions, programs and faculty in a variety of categories have taken note. Nearly one million patient visits each year. Educating thousands of future health care providers. You get the picture. Immerse yourself in more facts and stats than you probably need about Portland's largest employer, Oregon's provider of care to every corner of the state, and one of the nation's top 28 biomedical research institutions. Oregon Health & Science University is the state’s only academic health center. It provides an uncommon array of services from providing the state’s most comprehensive health care, to educating the next generation of clinicians and biomedical researchers, to achieving breakthroughs and innovations.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Fennec Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Fennec Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Fennec Pharmaceuticals, Inc..